- All sections
- C - Chemistry; metallurgy
- C07D - Heterocyclic compounds
- C07D 473/30 - Oxygen atom attached in position 6, e.g. hypoxanthine
Patent holdings for IPC class C07D 473/30
Total number of patents in this class: 164
10-year publication summary
|
10
|
16
|
12
|
14
|
18
|
9
|
5
|
13
|
5
|
2
|
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| BeiGene, Ltd. | 319 |
9 |
| Genentech, Inc. | 3742 |
6 |
| Amgen Inc. | 3779 |
6 |
| SHY Therapeutics LLC | 24 |
6 |
| Impetis Biosciences Ltd. | 29 |
6 |
| Medivir AB | 142 |
5 |
| Merck Sharp & Dohme LLC | 3689 |
5 |
| F. Hoffmann-La Roche AG | 7958 |
4 |
| Merck Sharp & Dohme Corp. | 2247 |
4 |
| Takeda Pharmaceutical Company Limited | 2961 |
3 |
| ATIR Holding S.A. | 18 |
3 |
| Auburn University | 506 |
3 |
| Irm LLC | 215 |
3 |
| Tango Therapeutics, Inc. | 29 |
3 |
| Novartis AG | 11238 |
2 |
| The Regents of the University of California | 18943 |
2 |
| Commissariat à l'énergie atomique et aux energies alternatives | 10525 |
2 |
| Ardea Biosciences, Inc. | 79 |
2 |
| Consejo Superior de Investigaciones Cientificas (csic) | 1254 |
2 |
| Eli Lilly and Company | 3645 |
2 |
| Other owners | 86 |